1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol has been researched along with haloperidol in 1 studies
Studies (1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol) | Trials (1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol) | Recent Studies (post-2010) (1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
---|---|---|---|---|---|
9 | 4 | 1 | 20,330 | 1,753 | 3,294 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breier, A; Buchanan, RW; Goldstein, DS; Holmes, C; Listwak, S; Waltrip, RW | 1 |
1 trial(s) available for 1-((3-hydroxy-4-methoxy)-1-naphthoxy)-2,3-propanediol and haloperidol
Article | Year |
---|---|
The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenocorticotropic Hormone; Adult; Analysis of Variance; Clozapine; Dihydroxyphenylalanine; Double-Blind Method; Female; Haloperidol; Hemodynamics; Humans; Hydrocortisone; Male; Naphthols; Norepinephrine; Propylene Glycols; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1994 |